Knowledge

Transcranial magnetic stimulation

Source đź“ť

786:
stimulation targets a large area of poorly characterized tissue. An undefined dose and target of radiation can destroy healthy cells during a treatment procedure. Because it is unclear whether magnetic fields reach only those neural structures of the brain that need treatment, this uncertainty challenges the selection of treatment for neurological disorders by magnetic fields. Thus, magnetic field exposure may destroy healthy neuronal structures. The inability to localize the effect of stimulation makes it challenging to target stimulation only to the desired neural networks.
314: 172: 40: 737:
sample size, lack of a validated sham comparison in randomized controlled studies, and variable uses of outcome measures. Other commercial insurance plans whose 2013 medical coverage policies stated that the role of TMS in the treatment of depression and other disorders had not been clearly established or remained investigational included
2912: 768:
In August 2012, the jurisdiction covering Arkansas, Louisiana, Mississippi, Colorado, Texas, Oklahoma, and New Mexico determined that there was insufficient evidence to cover the treatment, but the same jurisdiction subsequently determined that Medicare would cover TMS for the treatment of depression
439:
depending on the intensity of stimulation, coil orientation, and frequency. Low frequency rTMS with a stimulus frequency less than 1 Hz is believed to inhibit cortical firing while a stimulus frequency greater than 1 Hz, or high frequency, is believed to provoke it. Though its mechanism is
699:
Subsequently, in 2015, NICE approved the use of TMS for the treatment of depression in the UK and IPG542 replaced IPG242. NICE said "The evidence on repetitive transcranial magnetic stimulation for depression shows no major safety concerns. The evidence on its efficacy in the short-term is adequate,
473:
A number of different types of coils exist, each of which produce different magnetic fields. The round coil is the original used in TMS. Later, the figure-eight (butterfly) coil was developed to provide a more focal pattern of activation in the brain, and the four-leaf coil for focal stimulation of
1592:
Lefaucheur, Jean-Pascal; André-Obadia, Nathalie; Antal, Andrea; Ayache, Samar S.; Baeken, Chris; Benninger, David H.; Cantello, Roberto M.; Cincotta, Massimo; de Carvalho, Mamede; De Ridder, Dirk; Devanne, Hervé; Di Lazzaro, Vincenzo; Filipović, Saša R.; Hummel, Friedhelm C.; Jääskeläinen, Satu K.
1896:
Bersani, F.S.; Minichino, A.; Enticott, P.G.; Mazzarini, L.; Khan, N.; Antonacci, G.; Raccah, R.N.; Salviati, M.; Delle Chiaie, R.; Bersani, G.; Fitzgerald, P.B.; Biondi, M. (January 2013). "Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review".
1885:
Baur D, Galevska D, Hussain S, Cohen LG, Ziemann U, Zrenner C. Induction of LTD-like corticospinal plasticity by low-frequency rTMS depends on pre-stimulus phase of sensorimotor ÎĽ-rhythm. Brain Stimul. 2020 Nov-Dec;13(6):1580-1587. doi: 10.1016/j.brs.2020.09.005. Epub 2020 Sep 17. PMID 32949780;
1322:
Chen, Robert; Cros, Didier; Curra, Antonio; Di Lazzaro, Vincenzo; Lefaucheur, Jean-Pascal; Magistris, Michel R.; Mills, Kerry; Rösler, Kai M.; Triggs, William J.; Ugawa, Yoshikazu; Ziemann, Ulf (March 2008). "The clinical diagnostic utility of transcranial magnetic stimulation: Report of an IFCN
736:
issued a medical policy for TMS in 2013 that stated there is insufficient evidence that the procedure is beneficial for health outcomes in patients with depression. UnitedHealthcare noted that methodological concerns raised about the scientific evidence studying TMS for depression include small
695:
In January 2014, NICE reported the results of an evaluation of TMS for treating and preventing migraine (IPG 477). NICE found that short-term TMS is safe but there is insufficient evidence to evaluate safety for long-term and frequent uses. It found that evidence on the efficacy of TMS for the
551:
In 1980 Merton and Morton successfully used transcranial electrical stimulation (TES) to stimulate the motor cortex. However, this process was very uncomfortable, and subsequently Anthony T. Barker began to search for an alternative to TES. He began exploring the use of magnetic fields to alter
781:
First, the uncertainty in the dose (time and technical field parameters) for correct and healthy stimulation is a complex and challenging issue. While neurophysiology lacks knowledge about the nature of such a treatment of nervous diseases at the cellular level, this method involves excessive
453:
Most devices use a coil shaped like a figure-eight to deliver a shallow magnetic field that affects more superficial neurons in the brain. Differences in magnetic coil design are considered when comparing results, with important elements including the type of material, geometry and specific
785:
Second, it is impossible to localize the effect of stimulation on specific neural networks that need to be treated. Neuronal activity related to mental processes, neuronal correlates of cognitive functions are still intriguing questions for contemporary research. Non-invasive brain tissue
2919: 432:' (flashes of light) might be perceived by the subject. In most other areas of the cortex, there is no conscious effect, but behaviour may be altered (e.g., slower reaction time on a cognitive task), or changes in brain activity may be detected using diagnostic equipment. 474:
peripheral nerves. The double-cone coil conforms more to the shape of the head. The Hesed (H-core), circular crown and double cone coils allow more widespread activation and a deeper magnetic penetration. They are supposed to impact deeper areas in the motor cortex and
3084: 383:
TMS usually stimulates to a depth from 2 to 4 cm below the surface, depending on the coil and intensity used. Consequently, only superficial brain areas can be affected. Deep TMS can reach up to 6 cm into the brain to stimulate deeper layers of the
552:
electrical signaling within the brain, and the first stable TMS devices were developed in 1985. They were originally intended as diagnostic and research devices, with evaluation of their therapeutic potential being a later development. The United States'
182:
Its use can be diagnostic and/or therapeutic. Effects vary based on frequency and intensity of the magnetic pulses as well as the length of treatment, which dictates the total number of pulses given. TMS treatments are approved by the FDA in the US and by
3092: 691:
NICE evaluated TMS for severe depression (IPG 242) in 2007, and subsequently considered TMS for reassessment in January 2011 but did not change its evaluation. The Institute found that TMS is safe, but there is insufficient evidence for its efficacy.
461:
active material ('solid core'). Solid cores result in more efficient transfer of electrical energy to a magnetic field and reduce energy loss to heat, and so can be operated with the higher volume of therapy protocols without interruption due to
379:
neurons at that site. The induced electric field inside the brain tissue causes a change in transmembrane potentials resulting in depolarization or hyperpolarization of neurons, causing them to be more or less excitable, respectively.
388:, such as that which controls leg motion. The path of this current can be difficult to model because the brain is irregularly shaped with variable internal density and water content, leading to a nonuniform magnetic field strength and 2877: 203:
TMS can be used clinically to measure activity and function of specific brain circuits in humans, most commonly with single or paired magnetic pulses. The most widely accepted use is in measuring the connection between the
2980: 897:
Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, et al. (February 2020). "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)".
2241: 348:
to the plane of the coil. The changing magnetic field then induces an electric current in the brain that activates nearby nerve cells in a manner similar to a current applied superficially at the cortical surface.
934:
The present work only provides arguments to be confident that some rTMS protocols do something that is different from a placebo in some indications, but not that the results obtained are clinically relevant
1485:"The number of stimuli required to reliably assess corticomotor excitability and primary motor cortical representations using transcranial magnetic stimulation (TMS): a systematic review and meta-analysis" 2103:
Horvath JC, Perez JM, Forrow L, Fregni F, Pascual-Leone A (March 2011). "Transcranial magnetic stimulation: a historical evaluation and future prognosis of therapeutically relevant ethical concerns".
252:
Although TMS is generally regarded as safe, risks are increased for therapeutic rTMS compared to single or paired diagnostic TMS. Adverse effects generally increase with higher frequency stimulation.
3054: 2814: 2008:
Machado S, Bittencourt J, Minc D, Portella CE, Velasques B, Cunha M, et al. (2008). "Therapeutic applications of repetitive transcranial magnetic stimulation in clinical neurorehabilitation".
3344:
Sparing R, Mottaghy FM (2008). "Noninvasive brain stimulation with transcranial magnetic or direct current stimulation (TMS/tDCS)-From insights into human memory to therapy of its dysfunction".
1973:
Roth BJ, Maccabee PJ, Eberle LP, Amassian VE, Hallett M, Cadwell J, et al. (February 1994). "In vitro evaluation of a 4-leaf coil design for magnetic stimulation of peripheral nerve".
321: 121:
connected to the scalp. The stimulator generates a changing electric current within the coil which creates a varying magnetic field, inducing a current within a region in the brain itself.
1017:
Nauczyciel C, Hellier P, Morandi X, Blestel S, Drapier D, Ferre JC, et al. (April 2011). "Assessment of standard coil positioning in transcranial magnetic stimulation in depression".
244:, and TMS treatment is covered by most private insurance plans as well as by traditional Medicare, but for no condition does the evidence rise to the level of showing clinical relevance. 2884: 2991: 3328:
Siebner HR, Hartwigsen G, Kassuba T, Rothwell JC (2009). "How does transcranial magnetic stimulation modify neuronal activity in the brain? Implications for studies of cognition".
757:
Policies for Medicare coverage vary among local jurisdictions within the Medicare system, and Medicare coverage for TMS has varied among jurisdictions and with time. For example:
700:
although the clinical response is variable. Repetitive transcranial magnetic stimulation for depression may be used with normal arrangements for clinical governance and audit."
2849: 3208: 3113: 2259: 570: 3143: 3262: 2382: 17: 959:"Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines" 3062: 688:) make decisions about funding after considering the clinical effectiveness of the procedure and whether the procedure represents value for money for the NHS. 3315:
Grimaldi G, Argyropoulos GP, Boehringer A, Celnik P, Edwards MJ, Ferrucci R, et al. (2014). "Non-invasive cerebellar stimulation--a consensus paper" (PDF).
680:(NHS) in England, Wales, Scotland and Northern Ireland (UK). NICE guidance does not cover whether or not the NHS should fund a procedure. Local NHS bodies ( 2825: 1843:
Fitzgerald PB, Fountain S, Daskalakis ZJ (December 2006). "A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition".
782:
exposure of the brain to an intense field, which is several times and even orders of magnitude higher than natural electromagnetic fields in the brain.
2277: 673: 184: 1627:
Zangen A, Roth Y, Voller B, Hallett M (April 2005). "Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil".
356:(MRI), and the pulse generally reaches no more than 5 centimeters into the brain unless using a modified coil and technique for deeper stimulation. 573:
clearance for the assessment of the primary motor cortex for pre-procedural planning in December 2009 and for neurosurgical planning in June 2011.
435:
Repetitive TMS produces longer-lasting effects which persist past the period of stimulation. rTMS can increase or decrease the excitability of the
509:(1737–1798) undertook research on the effects of electricity on the body in the late-eighteenth century and laid the foundations for the field of 2784: 765:, Medicare covered TMS for the first time in the United States. However, that jurisdiction later decided to end coverage after October, 2013. 882: 2037:"Comparative motor effectiveness of non-invasive brain stimulation techniques in patients with Parkinson's disease: A network meta-analysis" 1582:
V. Walsh and A. Pascual-Leone, "Transcranial Magnetic Stimulation: A Neurochronometrics of Mind." Cambridge, Massachusetts: MIT Press, 2003.
371:
in strength. Directing the magnetic field pulse at a targeted area in the brain causes a localized electrical current which can then either
831: 2411: 188: 3270: 3241: 3212: 3088: 3058: 2623: 2519:"Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis" 1537: 3289:
Benussi A, Pascual-Leone A, Borroni B (2020). "Non-Invasive Cerebellar Stimulation in Neurodegenerative Ataxia: A Literature Review".
2947: 2860: 2242:"FDA clears Nexstim´s Navigated Brain Stimulation for non-invasive cortical mapping prior to neurosurgery – Archive – Press Releases" 470:, shape, and depth of penetration. Differences in coil material and its power supply also affect magnetic pulse width and duration. 2446: 696:
treatment of migraine is limited in quantity, that evidence for the prevention of migraine is limited in both quality and quantity.
3369: 3019: 2878:"Medical Coverage Policy: Transcranial Magnetic Stimulation for Treatment of Depression and Other Psychiatric/Neurologic Disorders" 659:(negative symptoms) and to aid smoking cessation. One review found tentative benefit for cognitive enhancement in healthy people. 836: 192: 3121: 3399: 528:
Work to directly stimulate the human brain with electricity started in the late 1800s, and by the 1930s the Italian physicians
3174: 2617:
Petrosino, Nicholas J.; Cosmo, Camila; Berlow, Yosef A.; Zandvakili, Amin; van ’t Wout-Frank, Mascha; Philip, Noah S. (2021).
1957: 1776: 1564: 1467: 841: 3175:"Transcranial Magnetic Stimulation Cites Influence of New England Comparative Effectiveness Public Advisory Council (CEPAC)" 3150: 1195:
Rossini PM, Rossi S (February 2007). "Transcranial magnetic stimulation: diagnostic, therapeutic, and research potential".
2358: 1397:"Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion" 826: 1240:"Contribution of transcranial magnetic stimulation to the understanding of functional recovery mechanisms after stroke" 801: 721: 287:
During the procedure, a magnetic coil is positioned at the head of the person receiving the treatment using anatomical
1940:
Riehl M (2008). "TMS Stimulator Design". In Wassermann EM, Epstein CM, Ziemann U, Walsh V, Paus T, Lisanby SH (eds.).
1120: 602: 216:
to evaluate damage related to past or progressive neurologic insult. TMS has utility as a diagnostic instrument for
3404: 611:
In 2023, US FDA authorized the use of TMS developed by the U.S. company Neuronetics Inc. in the treatment of OCD.
1287:
Nowak DA, Bösl K, Podubeckà J, Carey JR (2010). "Noninvasive brain stimulation and motor recovery after stroke".
608:
In 2020, US FDA authorized the use of TMS developed by the U.S. company MagVenture Inc. in the treatment of OCD.
292: 2568:"Retrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson's Disease" 2161:"History, Studies and Specific Uses of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treating Epilepsy" 3182: 816: 652: 263:
have been reported, but are rare. Other adverse effects include short term discomfort, pain, brief episodes of
299:. The coil is then connected to a pulse generator, or stimulator, that delivers electric current to the coil. 3364: 221: 2470:"H-coil repetitive transcranial magnetic stimulation for treatment of temporal lobe epilepsy: A case report" 2260:"Nexstim Announces FDA Clearance for NexSpeech® – Enabling Noninvasive Speech Mapping Prior to Neurosurgery" 3424: 2343: 2339:"FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder" 2338: 806: 796: 553: 417: 3419: 3414: 1595:"Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)" 1110: 400:
The effects of TMS can be divided based on frequency, duration and intensity (amplitude) of stimulation:
376: 593:
In August 2018, the US Food and Drug Administration (US FDA) authorized the use of TMS developed by the
2785:"Medical Policy: Transcranial Magnetic Stimulation for Depression and Other Neuropsychiatric Disorders" 353: 236:
There is some evidence that TMS may have applications for a number of conditions including depression,
2792: 2566:
Torres F, Villalon E, Poblete P, Moraga-Amaro R, Linsambarth S, Riquelme R, et al. (2015-10-26).
3379: 3085:"Local Coverage Determination (LCD) for Repetitive Transcranial Magnetic Stimulation (rTMS) (L32228)" 821: 811: 778:
There are serious concerns about stimulating brain tissue using non-invasive magnetic field methods:
644: 537: 463: 329: 308: 272: 213: 114: 3020:"Medical Policy: Transcranial Magnetic Stimulation as a Treatment of Depression and Other Disorders" 1664:
Huang YZ, Sommer M, Thickbroom G, Hamada M, Pascual-Leonne A, Paulus W, et al. (January 2009).
3409: 3394: 3389: 3384: 2468:
Gersner R, Oberman L, Sanchez MJ, Chiriboga N, Kaye HL, Pascual-Leone A, et al. (2016-01-01).
494:, early results suggest that low frequency stimulation may have an effect on medication associated 340:. A plastic-enclosed coil of wire is held next to the skull and when activated, produces a varying 68: 3374: 1594: 846: 677: 2948:"Clinical Policy Bulletin: Transcranial Magnetic Stimulation and Cranial Electrical Stimulation" 1148:"A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee" 1350:
van den Noort M, Lim S, Bosch P (December 2014). "Recognizing the risks of brain stimulation".
648: 628: 620: 491: 441: 288: 209: 125: 482:, for example, though the increased depth comes at the cost of a less focused magnetic pulse. 1949: 1945: 389: 404:
Single or paired pulse TMS causes neurons in the neocortex under the site of stimulation to
3149:. The New England Comparative Effectiveness Public Advisory Council (CEPAC). Archived from 1764: 413: 205: 2955: 2672:"Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS)" 440:
not clear, it has been suggested as being due to a change in synaptic efficacy related to
359:
Transcranial magnetic stimulation is achieved by quickly discharging current from a large
8: 457:
The core material may be either a magnetically inert substrate ('air core'), or a solid,
436: 3030: 2069: 2692: 2671: 2647: 2618: 2594: 2567: 2543: 2518: 2494: 2469: 2315: 2290: 2202:"Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS)" 2177: 2160: 2136: 2120: 1922: 1868: 1820: 1793: 1741: 1716: 1690: 1665: 1652: 1511: 1484: 1423: 1396: 1264: 1239: 1220: 1208: 1172: 1147: 1146:
Groppa S, Oliviero A, Eisen A, Quartarone A, Cohen LG, Mall V, et al. (May 2012).
1062:"Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS)" 1042: 996: 983: 958: 733: 681: 545: 518: 256: 225: 187:
in the UK for the treatment of depression and are provided by private clinics and some
140: 3263:"LCD L33660 – Transcranial Magnetic Stimulation (TMS) for the Treatment of Depression" 3015: 2697: 2683: 2652: 2599: 2548: 2499: 2320: 2223: 2182: 2128: 2074: 2056: 2017: 1990: 1986: 1953: 1914: 1860: 1825: 1772: 1746: 1695: 1644: 1560: 1516: 1463: 1428: 1377: 1304: 1269: 1212: 1177: 1116: 1091: 1083: 1034: 1000: 988: 925: 746: 717: 510: 276: 260: 156: 144: 52: 3233: 2140: 1926: 1872: 1656: 1363: 1224: 1046: 39: 3186: 2908: 2687: 2679: 2642: 2632: 2589: 2579: 2538: 2530: 2489: 2481: 2310: 2302: 2213: 2172: 2112: 2064: 2048: 1982: 1906: 1852: 1815: 1805: 1736: 1728: 1685: 1677: 1636: 1606: 1506: 1496: 1455: 1418: 1408: 1367: 1359: 1332: 1296: 1259: 1251: 1204: 1167: 1159: 1073: 1030: 1026: 978: 970: 915: 907: 709: 708:
In 2013, several commercial health insurance plans in the United States, including
636: 467: 425: 421: 409: 241: 110: 102: 3178: 2534: 2383:"FDA clears OCD motor threshold cap for transcranial magnetic stimulation system" 1910: 1856: 1640: 1610: 1447: 1336: 1163: 974: 911: 514: 364: 74: 3209:"Local Coverage Determination (LCD): Transcranial Magnetic Stimulation (L32038)" 2218: 2201: 2052: 1078: 1061: 732:, covered TMS for the treatment of depression for the first time. In contrast, 3144:"Coverage Policy Analysis: Repetitive Transcranial Magnetic Stimulation (rTMS)" 2485: 2278:
Secrets Of The De Novo Pathway, Part 1: Why Aren't More Device Makers Using It?
685: 541: 522: 405: 372: 341: 268: 136:, but has no demonstrated clinical worth for treatment of any other condition. 106: 3141: 2747:. London: National Institute for Health and Clinical Excellence. January 2014. 2637: 1681: 1501: 1459: 3358: 2584: 2060: 1757: 1255: 1087: 656: 506: 458: 345: 160: 133: 118: 2733:. London: National Institute for Health and Clinical Excellence. 2011-03-04. 2116: 2036: 2715: 2701: 2656: 2603: 2552: 2503: 2324: 2227: 2186: 2132: 2078: 2021: 1918: 1864: 1829: 1810: 1750: 1699: 1648: 1520: 1432: 1395:
Dobek CE, Blumberger DM, Downar J, Daskalakis ZJ, Vila-Rodriguez F (2015).
1381: 1308: 1273: 1216: 1181: 1095: 1038: 992: 929: 729: 529: 479: 385: 368: 237: 3330:
Cortex; A Journal Devoted to the Study of the Nervous System and Behavior.
2758: 2744: 2730: 1994: 1794:"Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS" 1732: 1300: 867: 466:. Varying the geometric shape of the coil itself can cause variations in 320: 762: 337: 191:. TMS stimulates cortical tissue without the pain sensations produced in 2745:"Transcranial magnetic stimulation for treating and preventing migraine" 2124: 920: 3302:
Rosa, MA; Lisanby, SH (2012). "Somatic treatments for mood disorders".
1413: 1372: 713: 624: 533: 495: 475: 217: 57: 3114:"Important Treatment Option for Depression Receives Medicare Coverage" 2619:"Transcranial magnetic stimulation for post-traumatic stress disorder" 2306: 868:
Transcranial magnetic stimulation for treating and preventing migraine
84: 1452:
Repetitive Transcranial Magnetic Stimulation for Depressive Disorders
1060:
Klomjai, Wanalee; Katz, Rose; Lackmy-Vallée, Alexandra (2015-09-01).
598: 444:(LTP) and long-term depression like plasticity (LTD-like plasticity). 429: 360: 264: 148: 129: 61: 2883:. Blue Cross Blue Shield of Rhode Island. 2012-05-15. Archived from 1763: 881:
Michael Craig Miller for Harvard Health Publications. July 26, 2012
725: 640: 152: 3206: 2981:"Cigna Medical Coverage Policy: Transcranial Magnetic Stimulation" 2731:"Transcranial magnetic stimulation for severe depression (IPG242)" 2359:"MagVenture receives FDA clearance for OCD | Clinical TMS Society" 313: 2565: 2291:"Neurostimulation for Treatment of Migraine and Cluster Headache" 1895: 1591: 155:, and inadvertent current induction in implanted devices such as 2859:. Blue Cross Blue Shield of Nebraska. 2011-05-18. Archived from 117:. An electric pulse generator, or stimulator, is connected to a 3234:"LCD L32752 – Transcranial Magnetic Stimulation for Depression" 3120:. PBN.com: Providence Business News. 2012-03-30. Archived from 2412:"Brainsway reports positive Deep TMS system trial data for OCD" 1394: 1016: 896: 632: 594: 498:, and that high frequency stimulation improves motor function. 296: 2616: 2517:
Chou YH, Hickey PT, Sundman M, Song AW, Chen NK (April 2015).
2467: 2447:"Brainsway's Deep TMS EU Cleared for Neuropathic Chronic Pain" 2007: 1559:(3rd ed.). New York: Cambridge Univ. Press. p. 121. 2976: 2943: 2759:"Repetitive transcranial magnetic stimulation for depression" 1145: 742: 738: 703: 333: 3340: 3338: 3142:
The Institute for Clinical and Economic Review (June 2012).
2815:"National Medical Policy: Transcranial Magnetic Stimulation" 1842: 883:
Magnetic stimulation: a new approach to treating depression?
1663: 662: 171: 1972: 124:
TMS has shown diagnostic and therapeutic potential in the
3335: 1554: 1482: 2199: 2102: 1059: 581:
TMS is approved as a Class II medical device under the "
179:
TMS does not require surgery or electrode implantation.
3260: 3231: 1717:"Parameterization of transcranial magnetic stimulation" 1626: 1321: 1286: 564: 544:, and ultimately overused, as it began to be seen as a 2276:
Michael Drues, for Med Device Online. 5 February 2014
1767:, Davey N, Rothwell J, Wassermann EM, Puri BK (2002). 1454:. Berlin Heidelberg: Springer-Verlag. pp. 81–90. 588: 525:, and that changing one could induce its counterpart. 2516: 2200:
Klomjai W, Katz R, Lackmy-Vallée A (September 2015).
1555:
Cacioppo JT, Tassinary LG, Berntson GG, eds. (2007).
1349: 1666:"Consensus: New methodologies for brain stimulation" 1483:
Cavaleri R, Schabrun SM, Chipchase LS (March 2017).
1445: 275:
of electrical currents in implanted devices such as
175:
A magnetic coil is positioned on the patient's head.
3332:
45 (9): 1035–1042. doi:10.1016/j.cortex.2009.02.007
1975:
Electroencephalography and Clinical Neurophysiology
571:
Federal Food, Drug, and Cosmetic Act§Section 510(k)
147:. Other potential issues include discomfort, pain, 454:characteristics of the associated magnetic pulse. 3207:National Government Services, Inc. (2013-10-25). 2763:National Institute for Health and Care Excellence 674:National Institute for Health and Care Excellence 352:The magnetic field is about the same strength as 3356: 3348:44 (4): 329–337. doi:10.1016/j.ymeth.2007.02.001 2907: 2158: 416:, it produces muscle activity referred to as a 139:Adverse effects of TMS appear rare and include 3319:13 (1): 121–138. doi:10.1007/s12311-013-0514-7 2441: 2439: 2437: 2435: 2433: 2206:Annals of Physical and Rehabilitation Medicine 1791: 1066:Annals of Physical and Rehabilitation Medicine 2918:. UnitedHealthCare. p. 2. Archived from 2725: 2723: 2288: 1769:Handbook of Transcranial Magnetic Stimulation 1141: 1139: 3291:International Journal of Molecular Sciences. 2669: 2510: 1944:. Oxford: Oxford University Press. pp.  1889: 1194: 832:Transcranial alternating current stimulation 623:, various versions of deep TMS H-coils have 556:first approved TMS devices in October 2008. 3082: 2430: 2282: 1942:Oxford Handbook of Transcranial Stimulation 1714: 1439: 1237: 614: 332:to generate an electric current across the 267:, cognitive change, hearing loss, impaired 3271:Centers for Medicare and Medicaid Services 3242:Centers for Medicare and Medicaid Services 3213:Centers for Medicare and Medicaid Services 3089:Centers for Medicare and Medicaid Services 3059:Centers for Medicare and Medicaid Services 2812: 2720: 2624:Therapeutic Advances in Psychopharmacology 2418:. Medicaldevice-network. September 6, 2013 2098: 2096: 2094: 2092: 2090: 2088: 2035:Liu, Xuan; Li, Lei; Liu, Ye (2023-09-29). 1836: 1785: 1136: 752: 704:United States: commercial health insurance 38: 3306:37 (1): 102–116. doi:10.1038/npp.2011.225 2791:. Anthem, Inc. 2013-04-16. Archived from 2691: 2646: 2636: 2593: 2583: 2542: 2493: 2314: 2252: 2217: 2176: 2068: 1819: 1809: 1740: 1689: 1510: 1500: 1422: 1412: 1371: 1263: 1171: 1108: 1077: 982: 919: 877: 875: 395: 128:with a wide variety of disease states in 3267:Contractor's Determination Number L33660 3238:Contractor's Determination Number L32752 2034: 1578: 1576: 1315: 663:Coverage by health services and insurers 319: 255:The greatest immediate risk from TMS is 170: 113:at a specific area of the brain through 3014: 2610: 2289:Schwedt TJ, Vargas B (September 2015). 2154: 2152: 2150: 2085: 1798:Biology of Mood & Anxiety Disorders 1532: 1530: 952: 950: 948: 946: 944: 942: 860: 837:Transcranial direct-current stimulation 548:. This led to a backlash in the 1970s. 540:(ECT). ECT became widely used to treat 27:Brain stimulation using magnetic fields 18:Transcranial magnetic stimulation (TMS) 14: 3357: 3293:21 (6): 1948. doi:10.3390/ijms21061948 3261:Novitas Solutions, Inc. (2013-12-05). 3232:Novitas Solutions, Inc. (2013-12-04). 2406: 2404: 2402: 1401:Neuropsychiatric Disease and Treatment 1289:Restorative Neurology and Neuroscience 1231: 872: 485: 3055:"Medicare Administrative Contractors" 2975: 2942: 1966: 1939: 1792:Cusin C, Dougherty DD (August 2012). 1573: 1446:Fitzgerald PB, Daskalakis ZJ (2013). 1280: 1244:Neurorehabilitation and Neural Repair 1238:Dimyan MA, Cohen LG (February 2010). 1109:Lefaucher, Jean-Pascal (2019). "37". 956: 892: 890: 842:Transcranial random noise stimulation 2670:Luber B, Lisanby SH (January 2014). 2474:Epilepsy & Behavior Case Reports 2147: 1527: 1012: 1010: 939: 565:Speech mapping prior to neurosurgery 559: 2913:"Transcranial Magnetic Stimulation" 2399: 2234: 1448:"7. rTMS-Associated Adverse Events" 957:Rossi; et al. (January 2021). 827:Non-invasive cerebellar stimulation 589:Obsessive–compulsive disorder (OCD) 193:transcranial electrical stimulation 24: 2165:Iranian Journal of Child Neurology 1715:Rubens MT, Zanto TP (March 2012). 1209:10.1212/01.wnl.0000250268.13789.b2 887: 802:Cranial electrotherapy stimulation 312: 247: 25: 3436: 1007: 667: 95:Transcranial magnetic stimulation 44:Transcranial magnetic stimulation 33:Transcranial magnetic stimulation 2684:10.1016/j.neuroimage.2013.06.007 291:on the skull, in particular the 3370:Physical psychiatric treatments 3322: 3309: 3296: 3283: 3254: 3225: 3200: 3167: 3135: 3106: 3076: 3047: 3008: 2969: 2936: 2901: 2870: 2842: 2806: 2777: 2751: 2737: 2708: 2663: 2559: 2461: 2375: 2351: 2331: 2270: 2193: 2028: 2001: 1933: 1879: 1708: 1617: 1585: 1548: 1476: 1388: 1364:10.1126/science.346.6215.1307-a 1343: 569:Nexstim obtained United States 517:(1791–1867) discovered that an 420:(MEP) which can be recorded on 166: 3183:Central Vermont Medical Center 2159:Noohi S, Amirsalari S (2016). 1188: 1115:. Elsevier. pp. 559–580. 1112:Handbook of Clinical Neurology 1102: 1053: 1031:10.1016/j.psychres.2010.06.012 817:Low field magnetic stimulation 773: 676:(NICE) issues guidance to the 653:post-traumatic stress disorder 363:into a coil to produce pulsed 13: 1: 3400:Treatment of bipolar disorder 1538:"Brain Stimulation Therapies" 853: 603:obsessive–compulsive disorder 576: 448: 222:amyotrophic lateral sclerosis 3185:. 2012-02-06. Archived from 3061:. 2013-07-10. Archived from 2824:. Health Net. Archived from 2535:10.1001/jamaneurol.2014.4380 2344:Food and Drug Administration 1987:10.1016/0168-5597(94)90093-0 1911:10.1016/j.eurpsy.2012.02.006 1857:10.1016/j.clinph.2006.06.712 1641:10.1016/j.clinph.2004.11.008 1611:10.1016/j.clinph.2014.05.021 1557:Handbook of psychophysiology 1337:10.1016/j.clinph.2007.10.014 1164:10.1016/j.clinph.2012.01.010 975:10.1016/j.clinph.2020.10.003 912:10.1016/j.clinph.2019.11.002 807:Electrical brain stimulation 797:Cortical stimulation mapping 282: 231: 198: 7: 2988:Coverage Policy Number 0383 2219:10.1016/j.rehab.2015.05.005 2053:10.1097/MD.0000000000034960 1079:10.1016/j.rehab.2015.05.005 789: 259:, though this is uncommon. 101:) is a noninvasive form of 10: 3441: 3083:NHIC, Corp. (2013-10-24). 2486:10.1016/j.ebcr.2016.03.001 2363:www.clinicaltmssociety.org 1721:Journal of Neurophysiology 501: 354:magnetic resonance imaging 306: 302: 3029:. Regence. Archived from 2813:Health Net (March 2012). 2638:10.1177/20451253211049921 2449:. medGadget. July 3, 2012 2105:Journal of Medical Ethics 1771:. London: Edward Arnold. 1682:10.1016/j.brs.2008.09.007 1502:10.1186/s13643-017-0440-8 1460:10.1007/978-3-642-36467-9 822:My Beautiful Broken Brain 812:Electroconvulsive therapy 645:major depressive disorder 538:electroconvulsive therapy 478:controlling the legs and 330:electromagnetic induction 309:Electromagnetic induction 214:peripheral nervous system 115:electromagnetic induction 81: 67: 51: 37: 32: 3304:Neuropsychopharmacology. 2678:. 85 Pt 3 (3): 961–970. 2585:10.3389/fneur.2015.00210 1845:Clinical Neurophysiology 1629:Clinical Neurophysiology 1599:Clinical Neurophysiology 1325:Clinical Neurophysiology 1256:10.1177/1545968309345270 1152:Clinical Neurophysiology 963:Clinical Neurophysiology 615:Other neurological areas 392:throughout its tissues. 3405:Treatment of depression 2990:. Cigna. Archived from 2954:. Aetna. Archived from 2850:"Medical Policy Manual" 2480:(Supplement C): 52–56. 2117:10.1136/jme.2010.039966 847:Vagus nerve stimulation 753:United States: Medicare 678:National Health Service 2716:About NICE: What we do 2572:Frontiers in Neurology 2416:Medical Device Network 1811:10.1186/2045-5380-2-14 722:Blue Cross Blue Shield 621:European Economic Area 442:long-term potentiation 418:motor evoked potential 396:Frequency and duration 325: 317: 210:central nervous system 176: 126:central nervous system 2822:Policy Number NMP 508 1733:10.1152/jn.00716.2011 1301:10.3233/RNN-2010-0552 672:The United Kingdom's 324:TMS – butterfly coils 323: 316: 174: 109:is used to induce an 3365:Diagnostic neurology 2789:Policy No. BEH.00002 2010:Functional Neurology 769:after December 2013. 601:in the treatment of 521:had a corresponding 414:primary motor cortex 206:primary motor cortex 151:, cognitive change, 105:in which a changing 3425:Bioelectromagnetics 1899:European Psychiatry 1019:Psychiatry Research 866:NICE. January 2014 682:primary care trusts 649:Parkinson's disease 629:Alzheimer's disease 492:Parkinson's disease 486:Research directions 437:corticospinal tract 46:(schematic diagram) 3420:2008 introductions 3415:1985 introductions 2765:. 16 December 2015 1886:PMCID: PMC7710977. 1489:Systematic Reviews 1414:10.2147/NDT.S91126 519:electrical current 326: 318: 277:cardiac pacemakers 226:multiple sclerosis 189:VA medical centers 177: 2307:10.1111/pme.12792 1959:978-0-19-856892-6 1851:(12): 2584–2596. 1778:978-0-340-72009-7 1670:Brain Stimulation 1605:(11): 2150–2206. 1593:(November 2014). 1566:978-0-521-84471-0 1469:978-3-642-36466-2 900:Clin Neurophysiol 761:In early 2012 in 718:Kaiser Permanente 560:Regulatory status 511:electrophysiology 459:ferromagnetically 424:. If used on the 412:. If used in the 408:and discharge an 103:brain stimulation 92: 91: 16:(Redirected from 3432: 3380:Magnetic devices 3349: 3342: 3333: 3326: 3320: 3313: 3307: 3300: 3294: 3287: 3281: 3280: 3278: 3277: 3258: 3252: 3251: 3249: 3248: 3229: 3223: 3222: 3220: 3219: 3204: 3198: 3197: 3195: 3194: 3171: 3165: 3164: 3162: 3161: 3155: 3148: 3139: 3133: 3132: 3130: 3129: 3110: 3104: 3103: 3101: 3100: 3091:. Archived from 3080: 3074: 3073: 3071: 3070: 3051: 3045: 3044: 3042: 3041: 3035: 3024: 3012: 3006: 3005: 3003: 3002: 2996: 2985: 2973: 2967: 2966: 2964: 2963: 2940: 2934: 2933: 2931: 2930: 2924: 2917: 2909:UnitedHealthcare 2905: 2899: 2898: 2896: 2895: 2889: 2882: 2874: 2868: 2867: 2865: 2854: 2846: 2840: 2839: 2837: 2836: 2830: 2819: 2810: 2804: 2803: 2801: 2800: 2781: 2775: 2774: 2772: 2770: 2755: 2749: 2748: 2741: 2735: 2734: 2727: 2718: 2712: 2706: 2705: 2695: 2667: 2661: 2660: 2650: 2640: 2614: 2608: 2607: 2597: 2587: 2563: 2557: 2556: 2546: 2514: 2508: 2507: 2497: 2465: 2459: 2458: 2456: 2454: 2443: 2428: 2427: 2425: 2423: 2408: 2397: 2396: 2394: 2393: 2379: 2373: 2372: 2370: 2369: 2355: 2349: 2348: 2335: 2329: 2328: 2318: 2301:(9): 1827–1834. 2286: 2280: 2274: 2268: 2267: 2264:businesswire.com 2256: 2250: 2249: 2238: 2232: 2231: 2221: 2197: 2191: 2190: 2180: 2156: 2145: 2144: 2100: 2083: 2082: 2072: 2032: 2026: 2025: 2005: 1999: 1998: 1970: 1964: 1963: 1937: 1931: 1930: 1893: 1887: 1883: 1877: 1876: 1840: 1834: 1833: 1823: 1813: 1789: 1783: 1782: 1761: 1755: 1754: 1744: 1727:(5): 1257–1259. 1712: 1706: 1703: 1693: 1660: 1621: 1615: 1614: 1589: 1583: 1580: 1571: 1570: 1552: 1546: 1545: 1534: 1525: 1524: 1514: 1504: 1480: 1474: 1473: 1443: 1437: 1436: 1426: 1416: 1392: 1386: 1385: 1375: 1347: 1341: 1340: 1319: 1313: 1312: 1284: 1278: 1277: 1267: 1235: 1229: 1228: 1192: 1186: 1185: 1175: 1143: 1134: 1133: 1131: 1129: 1106: 1100: 1099: 1081: 1057: 1051: 1050: 1025:(2–3): 232–238. 1014: 1005: 1004: 986: 954: 937: 936: 923: 894: 885: 879: 870: 864: 734:UnitedHealthcare 643:, chronic pain, 637:bipolar disorder 426:occipital cortex 422:electromyography 410:action potential 367:between 2 and 3 242:neuropathic pain 111:electric current 85:edit on Wikidata 77: 42: 30: 29: 21: 3440: 3439: 3435: 3434: 3433: 3431: 3430: 3429: 3410:Medical devices 3395:Neurotechnology 3390:Neuropsychology 3385:Neurophysiology 3355: 3354: 3353: 3352: 3343: 3336: 3327: 3323: 3314: 3310: 3301: 3297: 3288: 3284: 3275: 3273: 3259: 3255: 3246: 3244: 3230: 3226: 3217: 3215: 3205: 3201: 3192: 3190: 3179:Berlin, Vermont 3173: 3172: 3168: 3159: 3157: 3153: 3146: 3140: 3136: 3127: 3125: 3112: 3111: 3107: 3098: 3096: 3081: 3077: 3068: 3066: 3053: 3052: 3048: 3039: 3037: 3033: 3022: 3013: 3009: 3000: 2998: 2994: 2983: 2974: 2970: 2961: 2959: 2941: 2937: 2928: 2926: 2922: 2915: 2906: 2902: 2893: 2891: 2887: 2880: 2876: 2875: 2871: 2863: 2852: 2848: 2847: 2843: 2834: 2832: 2828: 2817: 2811: 2807: 2798: 2796: 2783: 2782: 2778: 2768: 2766: 2757: 2756: 2752: 2743: 2742: 2738: 2729: 2728: 2721: 2713: 2709: 2668: 2664: 2615: 2611: 2564: 2560: 2515: 2511: 2466: 2462: 2452: 2450: 2445: 2444: 2431: 2421: 2419: 2410: 2409: 2400: 2391: 2389: 2381: 2380: 2376: 2367: 2365: 2357: 2356: 2352: 2337: 2336: 2332: 2287: 2283: 2275: 2271: 2266:. 11 June 2012. 2258: 2257: 2253: 2240: 2239: 2235: 2198: 2194: 2157: 2148: 2101: 2086: 2033: 2029: 2006: 2002: 1971: 1967: 1960: 1938: 1934: 1894: 1890: 1884: 1880: 1841: 1837: 1790: 1786: 1779: 1765:Pascual-Leone A 1762: 1758: 1713: 1709: 1622: 1618: 1590: 1586: 1581: 1574: 1567: 1553: 1549: 1536: 1535: 1528: 1481: 1477: 1470: 1444: 1440: 1393: 1389: 1348: 1344: 1320: 1316: 1285: 1281: 1236: 1232: 1193: 1189: 1144: 1137: 1127: 1125: 1123: 1107: 1103: 1058: 1054: 1015: 1008: 955: 940: 895: 888: 880: 873: 865: 861: 856: 851: 792: 776: 755: 706: 686:hospital trusts 670: 665: 617: 591: 579: 567: 562: 515:Michael Faraday 513:. In the 1830s 504: 488: 451: 398: 365:magnetic fields 311: 305: 285: 250: 248:Adverse effects 234: 201: 169: 88: 73: 47: 45: 28: 23: 22: 15: 12: 11: 5: 3438: 3428: 3427: 3422: 3417: 3412: 3407: 3402: 3397: 3392: 3387: 3382: 3377: 3375:Electrotherapy 3372: 3367: 3351: 3350: 3334: 3321: 3308: 3295: 3282: 3253: 3224: 3199: 3166: 3134: 3105: 3075: 3046: 3018:(2013-06-01). 3007: 2979:(2013-01-15). 2968: 2946:(2013-10-11). 2935: 2911:(2013-12-01). 2900: 2869: 2866:on 2012-10-28. 2841: 2805: 2776: 2750: 2736: 2719: 2707: 2662: 2609: 2558: 2529:(4): 432–440. 2523:JAMA Neurology 2509: 2460: 2429: 2398: 2387:www.healio.com 2374: 2350: 2330: 2281: 2269: 2251: 2233: 2212:(4): 208–213. 2192: 2146: 2111:(3): 137–143. 2084: 2047:(39): e34960. 2027: 2016:(3): 113–122. 2000: 1965: 1958: 1932: 1888: 1878: 1835: 1784: 1777: 1756: 1707: 1705: 1704: 1661: 1635:(4): 775–779. 1616: 1584: 1572: 1565: 1547: 1526: 1475: 1468: 1438: 1387: 1358:(6215): 1307. 1342: 1331:(3): 504–532. 1314: 1295:(4): 531–544. 1279: 1250:(2): 125–135. 1230: 1203:(7): 484–488. 1187: 1158:(5): 858–882. 1135: 1121: 1101: 1072:(4): 208–213. 1052: 1006: 969:(1): 269–306. 938: 906:(2): 474–528. 886: 871: 858: 857: 855: 852: 850: 849: 844: 839: 834: 829: 824: 819: 814: 809: 804: 799: 793: 791: 788: 775: 772: 771: 770: 766: 754: 751: 705: 702: 669: 668:United Kingdom 666: 664: 661: 616: 613: 590: 587: 578: 575: 566: 563: 561: 558: 542:mental illness 536:had developed 523:magnetic field 503: 500: 487: 484: 450: 447: 446: 445: 433: 397: 394: 342:magnetic field 307:Main article: 304: 301: 284: 281: 269:working memory 249: 246: 233: 230: 200: 197: 168: 165: 161:defibrillators 107:magnetic field 90: 89: 82: 79: 78: 71: 65: 64: 55: 49: 48: 43: 35: 34: 26: 9: 6: 4: 3: 2: 3437: 3426: 3423: 3421: 3418: 3416: 3413: 3411: 3408: 3406: 3403: 3401: 3398: 3396: 3393: 3391: 3388: 3386: 3383: 3381: 3378: 3376: 3373: 3371: 3368: 3366: 3363: 3362: 3360: 3347: 3341: 3339: 3331: 3325: 3318: 3312: 3305: 3299: 3292: 3286: 3272: 3268: 3264: 3257: 3243: 3239: 3235: 3228: 3214: 3210: 3203: 3189:on 2012-03-25 3188: 3184: 3180: 3176: 3170: 3156:on 2013-12-13 3152: 3145: 3138: 3124:on 2013-04-05 3123: 3119: 3118:Press Release 3115: 3109: 3095:on 2014-02-17 3094: 3090: 3086: 3079: 3065:on 2014-02-14 3064: 3060: 3056: 3050: 3036:on 2014-12-09 3032: 3028: 3027:Policy No. 17 3021: 3017: 3011: 2997:on 2017-02-04 2993: 2989: 2982: 2978: 2972: 2958:on 2013-10-22 2957: 2953: 2949: 2945: 2939: 2925:on 2013-05-20 2921: 2914: 2910: 2904: 2890:on 2013-05-26 2886: 2879: 2873: 2862: 2858: 2857:Section IV.67 2851: 2845: 2831:on 2012-10-11 2827: 2823: 2816: 2809: 2795:on 2013-07-29 2794: 2790: 2786: 2780: 2764: 2760: 2754: 2746: 2740: 2732: 2726: 2724: 2717: 2711: 2703: 2699: 2694: 2689: 2685: 2681: 2677: 2673: 2666: 2658: 2654: 2649: 2644: 2639: 2634: 2630: 2626: 2625: 2620: 2613: 2605: 2601: 2596: 2591: 2586: 2581: 2577: 2573: 2569: 2562: 2554: 2550: 2545: 2540: 2536: 2532: 2528: 2524: 2520: 2513: 2505: 2501: 2496: 2491: 2487: 2483: 2479: 2475: 2471: 2464: 2448: 2442: 2440: 2438: 2436: 2434: 2417: 2413: 2407: 2405: 2403: 2388: 2384: 2378: 2364: 2360: 2354: 2347:. 2020-02-20. 2346: 2345: 2340: 2334: 2326: 2322: 2317: 2312: 2308: 2304: 2300: 2296: 2295:Pain Medicine 2292: 2285: 2279: 2273: 2265: 2261: 2255: 2247: 2243: 2237: 2229: 2225: 2220: 2215: 2211: 2207: 2203: 2196: 2188: 2184: 2179: 2174: 2170: 2166: 2162: 2155: 2153: 2151: 2142: 2138: 2134: 2130: 2126: 2122: 2118: 2114: 2110: 2106: 2099: 2097: 2095: 2093: 2091: 2089: 2080: 2076: 2071: 2066: 2062: 2058: 2054: 2050: 2046: 2042: 2038: 2031: 2023: 2019: 2015: 2011: 2004: 1996: 1992: 1988: 1984: 1980: 1976: 1969: 1961: 1955: 1951: 1947: 1943: 1936: 1928: 1924: 1920: 1916: 1912: 1908: 1904: 1900: 1892: 1882: 1874: 1870: 1866: 1862: 1858: 1854: 1850: 1846: 1839: 1831: 1827: 1822: 1817: 1812: 1807: 1803: 1799: 1795: 1788: 1780: 1774: 1770: 1766: 1760: 1752: 1748: 1743: 1738: 1734: 1730: 1726: 1722: 1718: 1711: 1701: 1697: 1692: 1687: 1683: 1679: 1675: 1671: 1667: 1662: 1658: 1654: 1650: 1646: 1642: 1638: 1634: 1630: 1625: 1624: 1620: 1612: 1608: 1604: 1600: 1596: 1588: 1579: 1577: 1568: 1562: 1558: 1551: 1543: 1539: 1533: 1531: 1522: 1518: 1513: 1508: 1503: 1498: 1494: 1490: 1486: 1479: 1471: 1465: 1461: 1457: 1453: 1449: 1442: 1434: 1430: 1425: 1420: 1415: 1410: 1407:: 2975–2987. 1406: 1402: 1398: 1391: 1383: 1379: 1374: 1369: 1365: 1361: 1357: 1353: 1346: 1338: 1334: 1330: 1326: 1318: 1310: 1306: 1302: 1298: 1294: 1290: 1283: 1275: 1271: 1266: 1261: 1257: 1253: 1249: 1245: 1241: 1234: 1226: 1222: 1218: 1214: 1210: 1206: 1202: 1198: 1191: 1183: 1179: 1174: 1169: 1165: 1161: 1157: 1153: 1149: 1142: 1140: 1124: 1122:9780444640321 1118: 1114: 1113: 1105: 1097: 1093: 1089: 1085: 1080: 1075: 1071: 1067: 1063: 1056: 1048: 1044: 1040: 1036: 1032: 1028: 1024: 1020: 1013: 1011: 1002: 998: 994: 990: 985: 980: 976: 972: 968: 964: 960: 953: 951: 949: 947: 945: 943: 935: 931: 927: 922: 917: 913: 909: 905: 901: 893: 891: 884: 878: 876: 869: 863: 859: 848: 845: 843: 840: 838: 835: 833: 830: 828: 825: 823: 820: 818: 815: 813: 810: 808: 805: 803: 800: 798: 795: 794: 787: 783: 779: 767: 764: 760: 759: 758: 750: 748: 744: 740: 735: 731: 727: 723: 719: 715: 711: 701: 697: 693: 689: 687: 683: 679: 675: 660: 658: 657:schizophrenia 654: 650: 646: 642: 638: 634: 630: 626: 622: 612: 609: 606: 604: 600: 596: 586: 584: 574: 572: 557: 555: 549: 547: 543: 539: 535: 531: 526: 524: 520: 516: 512: 508: 507:Luigi Galvani 499: 497: 493: 483: 481: 477: 471: 469: 465: 460: 455: 443: 438: 434: 431: 427: 423: 419: 415: 411: 407: 403: 402: 401: 393: 391: 387: 381: 378: 377:hyperpolarize 374: 370: 366: 362: 357: 355: 350: 347: 343: 339: 335: 331: 322: 315: 310: 300: 298: 294: 290: 280: 278: 274: 270: 266: 262: 258: 253: 245: 243: 239: 229: 227: 223: 219: 215: 211: 207: 196: 194: 190: 186: 180: 173: 164: 162: 158: 154: 150: 146: 142: 137: 135: 134:mental health 131: 127: 122: 120: 119:magnetic coil 116: 112: 108: 104: 100: 96: 86: 80: 76: 72: 70: 66: 63: 59: 56: 54: 50: 41: 36: 31: 19: 3345: 3329: 3324: 3316: 3311: 3303: 3298: 3290: 3285: 3274:. Retrieved 3266: 3256: 3245:. Retrieved 3237: 3227: 3216:. Retrieved 3202: 3191:. Retrieved 3187:the original 3169: 3158:. Retrieved 3151:the original 3137: 3126:. Retrieved 3122:the original 3117: 3108: 3097:. Retrieved 3093:the original 3078: 3067:. Retrieved 3063:the original 3049: 3038:. Retrieved 3031:the original 3026: 3010: 2999:. Retrieved 2992:the original 2987: 2971: 2960:. Retrieved 2956:the original 2951: 2938: 2927:. Retrieved 2920:the original 2903: 2892:. Retrieved 2885:the original 2872: 2861:the original 2856: 2844: 2833:. Retrieved 2826:the original 2821: 2808: 2797:. Retrieved 2793:the original 2788: 2779: 2767:. Retrieved 2762: 2753: 2739: 2710: 2675: 2665: 2628: 2622: 2612: 2575: 2571: 2561: 2526: 2522: 2512: 2477: 2473: 2463: 2453:December 16, 2451:. Retrieved 2422:December 16, 2420:. Retrieved 2415: 2390:. Retrieved 2386: 2377: 2366:. Retrieved 2362: 2353: 2342: 2333: 2298: 2294: 2284: 2272: 2263: 2254: 2245: 2236: 2209: 2205: 2195: 2168: 2164: 2108: 2104: 2044: 2040: 2030: 2013: 2009: 2003: 1981:(1): 68–74. 1978: 1974: 1968: 1941: 1935: 1905:(1): 30–39. 1902: 1898: 1891: 1881: 1848: 1844: 1838: 1801: 1797: 1787: 1768: 1759: 1724: 1720: 1710: 1673: 1669: 1632: 1628: 1619: 1602: 1598: 1587: 1556: 1550: 1541: 1492: 1488: 1478: 1451: 1441: 1404: 1400: 1390: 1355: 1351: 1345: 1328: 1324: 1323:committee". 1317: 1292: 1288: 1282: 1247: 1243: 1233: 1200: 1196: 1190: 1155: 1151: 1126:. Retrieved 1111: 1104: 1069: 1065: 1055: 1022: 1018: 966: 962: 933: 921:10362/147799 903: 899: 862: 784: 780: 777: 756: 730:Rhode Island 707: 698: 694: 690: 671: 618: 610: 607: 592: 582: 580: 568: 550: 527: 505: 489: 480:pelvic floor 472: 456: 452: 399: 386:motor cortex 382: 358: 351: 346:orthogonally 327: 286: 254: 251: 238:fibromyalgia 235: 202: 181: 178: 167:Medical uses 153:hearing loss 138: 123: 98: 94: 93: 3317:Cerebellum. 2952:Number 0469 2246:nexstim.com 1676:(1): 2–13. 1373:2066/133976 774:Limitations 763:New England 464:overheating 3359:Categories 3276:2014-02-17 3247:2014-02-17 3218:2014-02-17 3193:2012-10-12 3160:2013-12-11 3128:2012-10-11 3099:2014-02-17 3069:2014-02-14 3040:2013-12-11 3001:2013-12-11 2962:2013-12-11 2929:2013-12-11 2894:2012-09-05 2835:2012-09-05 2799:2013-12-11 2769:6 December 2676:NeuroImage 2392:2023-10-11 2368:2023-10-11 2171:(1): 1–8. 854:References 714:Health Net 625:CE marking 585:pathway". 577:Depression 496:dyskinesia 476:cerebellum 449:Coil types 430:phosphenes 406:depolarize 390:conduction 373:depolarize 271:, and the 218:myelopathy 157:pacemakers 58:Psychiatry 2061:1536-5964 1804:(1): 14. 1495:(1): 48. 1197:Neurology 1088:1877-0657 1001:225049093 599:Brainsway 361:capacitor 344:oriented 328:TMS uses 289:landmarks 283:Procedure 273:induction 265:hypomania 232:Treatment 199:Diagnosis 149:hypomania 130:neurology 62:neurology 53:Specialty 3346:Methods. 2702:23770409 2657:34733479 2604:26579065 2553:25686212 2504:27114902 2325:26177612 2228:26319963 2187:27057180 2141:13262044 2133:21106996 2125:23034661 2079:37773851 2070:10545289 2041:Medicine 2022:19152730 1927:29053871 1919:22559998 1873:31458874 1865:16890483 1830:22901565 1751:22072509 1700:20633398 1657:25101101 1649:15792886 1521:28264713 1433:26664122 1382:25504707 1309:20714076 1274:19767591 1225:19629888 1217:17296913 1182:22349304 1128:29 March 1096:26319963 1047:25100990 1039:20692709 993:33243615 930:31901449 790:See also 726:Nebraska 655:(PTSD), 641:epilepsy 597:company 530:Cerletti 468:focality 261:Seizures 257:fainting 212:and the 141:fainting 3016:Regence 2693:4083569 2648:8558793 2595:4620693 2578:: 210. 2544:4425190 2495:4832041 2316:4572909 2178:4815479 1995:7511524 1821:3514332 1742:3311692 1691:5507351 1512:5340029 1424:4670017 1352:Science 1265:2945387 1173:4890546 984:9094636 747:Regence 728:and of 619:In the 605:(OCD). 595:Israeli 583:de novo 546:panacea 502:History 303:Physics 208:of the 145:seizure 75:D050781 2700:  2690:  2655:  2645:  2602:  2592:  2551:  2541:  2502:  2492:  2323:  2313:  2226:  2185:  2175:  2139:  2131:  2123:  2077:  2067:  2059:  2020:  1993:  1956:  1925:  1917:  1871:  1863:  1828:  1818:  1775:  1749:  1739:  1698:  1688:  1655:  1647:  1563:  1519:  1509:  1466:  1431:  1421:  1380:  1307:  1272:  1262:  1223:  1215:  1180:  1170:  1119:  1094:  1086:  1045:  1037:  999:  991:  981:  928:  720:, and 710:Anthem 633:autism 369:teslas 297:nasion 224:, and 3154:(PDF) 3147:(PDF) 3034:(PDF) 3023:(PDF) 2995:(PDF) 2984:(PDF) 2977:Cigna 2944:Aetna 2923:(PDF) 2916:(PDF) 2888:(PDF) 2881:(PDF) 2864:(PDF) 2853:(PDF) 2829:(PDF) 2818:(PDF) 2714:NICE 2137:S2CID 2121:JSTOR 1950:25–32 1946:13–23 1923:S2CID 1869:S2CID 1653:S2CID 1623:See: 1221:S2CID 1043:S2CID 997:S2CID 743:Cigna 739:Aetna 338:skull 334:scalp 293:inion 83:[ 2771:2019 2698:PMID 2653:PMID 2600:PMID 2549:PMID 2500:PMID 2455:2013 2424:2013 2321:PMID 2224:PMID 2183:PMID 2129:PMID 2075:PMID 2057:ISSN 2018:PMID 1991:PMID 1954:ISBN 1915:PMID 1861:PMID 1826:PMID 1773:ISBN 1747:PMID 1696:PMID 1645:PMID 1561:ISBN 1542:NIMH 1517:PMID 1464:ISBN 1429:PMID 1378:PMID 1305:PMID 1270:PMID 1213:PMID 1178:PMID 1130:2024 1117:ISBN 1092:PMID 1084:ISSN 1035:PMID 989:PMID 926:PMID 745:and 684:and 627:for 534:Bini 532:and 490:For 336:and 295:and 240:and 185:NICE 143:and 132:and 69:MeSH 2688:PMC 2680:doi 2643:PMC 2633:doi 2590:PMC 2580:doi 2539:PMC 2531:doi 2490:PMC 2482:doi 2311:PMC 2303:doi 2214:doi 2173:PMC 2113:doi 2065:PMC 2049:doi 2045:102 1983:doi 1907:doi 1853:doi 1849:117 1816:PMC 1806:doi 1737:PMC 1729:doi 1725:107 1686:PMC 1678:doi 1637:doi 1633:116 1607:doi 1603:125 1507:PMC 1497:doi 1456:doi 1419:PMC 1409:doi 1368:hdl 1360:doi 1356:346 1333:doi 1329:119 1297:doi 1260:PMC 1252:doi 1205:doi 1168:PMC 1160:doi 1156:123 1074:doi 1027:doi 1023:186 979:PMC 971:doi 967:132 916:hdl 908:doi 904:131 724:of 554:FDA 428:, ' 375:or 159:or 99:TMS 3361:: 3337:^ 3269:. 3265:. 3240:. 3236:. 3211:. 3181:: 3177:. 3116:. 3087:. 3057:. 3025:. 2986:. 2950:. 2855:. 2820:. 2787:. 2761:. 2722:^ 2696:. 2686:. 2674:. 2651:. 2641:. 2631:. 2629:11 2627:. 2621:. 2598:. 2588:. 2574:. 2570:. 2547:. 2537:. 2527:72 2525:. 2521:. 2498:. 2488:. 2476:. 2472:. 2432:^ 2414:. 2401:^ 2385:. 2361:. 2341:. 2319:. 2309:. 2299:16 2297:. 2293:. 2262:. 2244:. 2222:. 2210:58 2208:. 2204:. 2181:. 2169:10 2167:. 2163:. 2149:^ 2135:. 2127:. 2119:. 2109:37 2107:. 2087:^ 2073:. 2063:. 2055:. 2043:. 2039:. 2014:23 2012:. 1989:. 1979:93 1977:. 1952:. 1948:, 1921:. 1913:. 1903:28 1901:. 1867:. 1859:. 1847:. 1824:. 1814:. 1800:. 1796:. 1745:. 1735:. 1723:. 1719:. 1694:. 1684:. 1672:. 1668:. 1651:. 1643:. 1631:. 1601:. 1597:. 1575:^ 1540:. 1529:^ 1515:. 1505:. 1491:. 1487:. 1462:. 1450:. 1427:. 1417:. 1405:11 1403:. 1399:. 1376:. 1366:. 1354:. 1327:. 1303:. 1293:28 1291:. 1268:. 1258:. 1248:24 1246:. 1242:. 1219:. 1211:. 1201:68 1199:. 1176:. 1166:. 1154:. 1150:. 1138:^ 1090:. 1082:. 1070:58 1068:. 1064:. 1041:. 1033:. 1021:. 1009:^ 995:. 987:. 977:. 965:. 961:. 941:^ 932:. 924:. 914:. 902:. 889:^ 874:^ 749:. 741:, 716:, 712:, 651:, 647:, 639:, 635:, 631:, 279:. 228:. 220:, 195:. 163:. 60:, 3279:. 3250:. 3221:. 3196:. 3163:. 3131:. 3102:. 3072:. 3043:. 3004:. 2965:. 2932:. 2897:. 2838:. 2802:. 2773:. 2704:. 2682:: 2659:. 2635:: 2606:. 2582:: 2576:6 2555:. 2533:: 2506:. 2484:: 2478:5 2457:. 2426:. 2395:. 2371:. 2327:. 2305:: 2248:. 2230:. 2216:: 2189:. 2143:. 2115:: 2081:. 2051:: 2024:. 1997:. 1985:: 1962:. 1929:. 1909:: 1875:. 1855:: 1832:. 1808:: 1802:2 1781:. 1753:. 1731:: 1702:. 1680:: 1674:2 1659:. 1639:: 1613:. 1609:: 1569:. 1544:. 1523:. 1499:: 1493:6 1472:. 1458:: 1435:. 1411:: 1384:. 1370:: 1362:: 1339:. 1335:: 1311:. 1299:: 1276:. 1254:: 1227:. 1207:: 1184:. 1162:: 1132:. 1098:. 1076:: 1049:. 1029:: 1003:. 973:: 918:: 910:: 97:( 87:] 20:)

Index

Transcranial magnetic stimulation (TMS)

Specialty
Psychiatry
neurology
MeSH
D050781
edit on Wikidata
brain stimulation
magnetic field
electric current
electromagnetic induction
magnetic coil
central nervous system
neurology
mental health
fainting
seizure
hypomania
hearing loss
pacemakers
defibrillators

NICE
VA medical centers
transcranial electrical stimulation
primary motor cortex
central nervous system
peripheral nervous system
myelopathy

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑